Anti-Amyloid Monoclonal Antibodies in Early Alzheimer Disease: Lecanemab and Donanemab. [PDF]
Demir ÜF, Karakuş Dilbaz F.
europepmc +1 more source
Multimodal Dementia Prediction With Large Language Models: Cross-Attention Over Text, Audio, and Image. [PDF]
Agbavor F, Liang H.
europepmc +1 more source
Multilevel genomic, transcriptomic, and epidemiologic evidence linking diabetic retinopathy to Alzheimer disease. [PDF]
Li J +8 more
europepmc +1 more source
Resilient Together Dyadic Intervention for Persons With Dementia and Their Partners: Protocol for a Feasibility Randomized Controlled Trial. [PDF]
Bannon SM +12 more
europepmc +1 more source
Perspectives from Alzheimer's Disease Research Centers site directors on the early steps and the lasting impact. [PDF]
Growdon JH +4 more
europepmc +1 more source
Rising burden of Alzheimer's disease and other dementias in Sierra Leone, 1990-2023: analysis of Global Burden of Disease 2023 estimates. [PDF]
Jalloh MB +11 more
europepmc +1 more source
Cost-effectiveness of amyloid-targeting therapies in a memory clinic population; a simulation study
van der Veere P +7 more
europepmc +1 more source

